2196841|t|[Central anticholinergic syndrome during postoperative period].
2196841|a|The central anticholinergic syndrome (CAS) includes central signs (somnolence, confusion, amnesia, agitation, hallucinations, dysarthria, ataxia, delirium, stupor, coma) and peripheral signs (dry mouth, dry skin, tachycardia, visual disturbances and difficulty in micturition). It occurs when central cholinergic sites are occupied by specific drugs and also as a result of an insufficient release of acetylcholine. The CAS can be caused by atropine sulphate, hyoscine (scopolamine), promethazine, benzodiazepines, opioids, halothane, influrane, ketamine. The incidence of CAS during the postoperative period depends on choice and dose of anaesthetic agents, type of surgery, patient's condition and diagnostic criteria. It is close to 10% following general anaesthesia and 4% following regional anaesthesia with sedation. The differential diagnosis of CAS includes an overdose of anaesthetic drugs or an alteration in pharmacokinetics, altered hydratation, electrolyte or acid-base state, hypoglycaemia, hypoxia, hypercapnia, hypocapnia, hyperthermia, hypothermia, hormonal disorders, neurological damage resulting from surgery, embolism, haemorrhage or trauma. The diagnosis of CAS is often determined by a process of exclusion and not actually made until a positive therapeutic response to physostigmine, a centrally active anticholinesterase agent has taken place.
2196841	1	33	Central anticholinergic syndrome	Disease	MESH:D064807
2196841	68	100	central anticholinergic syndrome	Disease	MESH:D064807
2196841	102	105	CAS	Disease	MESH:D064807
2196841	131	141	somnolence	Disease	MESH:D006970
2196841	154	161	amnesia	Disease	MESH:D000647
2196841	163	172	agitation	Disease	MESH:D011595
2196841	174	188	hallucinations	Disease	MESH:D006212
2196841	190	200	dysarthria	Disease	MESH:D004401
2196841	202	208	ataxia	Disease	MESH:D001259
2196841	210	218	delirium	Disease	MESH:D003693
2196841	220	226	stupor	Disease	MESH:D053608
2196841	228	232	coma	Disease	MESH:D003128
2196841	256	265	dry mouth	Disease	MESH:D014987
2196841	267	275	dry skin	Disease	MESH:D015352
2196841	277	288	tachycardia	Disease	MESH:D013610
2196841	290	309	visual disturbances	Disease	MESH:D014786
2196841	314	339	difficulty in micturition	Disease	MESH:D013575
2196841	465	478	acetylcholine	Chemical	MESH:D000109
2196841	484	487	CAS	Disease	MESH:D064807
2196841	505	522	atropine sulphate	Chemical	MESH:D001285
2196841	524	532	hyoscine	Chemical	MESH:D012601
2196841	534	545	scopolamine	Chemical	MESH:D012601
2196841	548	560	promethazine	Chemical	MESH:D011398
2196841	562	577	benzodiazepines	Chemical	MESH:D001569
2196841	588	597	halothane	Chemical	MESH:D006221
2196841	599	608	influrane	Chemical	-
2196841	610	618	ketamine	Chemical	-
2196841	637	640	CAS	Disease	MESH:D064807
2196841	740	747	patient	Species	9606
2196841	917	920	CAS	Disease	MESH:D064807
2196841	933	941	overdose	Disease	MESH:D062787
2196841	1054	1067	hypoglycaemia	Disease	
2196841	1069	1076	hypoxia	Disease	MESH:D000860
2196841	1078	1089	hypercapnia	Disease	MESH:D006935
2196841	1091	1101	hypocapnia	Disease	MESH:D016857
2196841	1103	1115	hyperthermia	Disease	MESH:D005334
2196841	1117	1128	hypothermia	Disease	MESH:D007035
2196841	1130	1148	hormonal disorders	Disease	MESH:C565870
2196841	1150	1169	neurological damage	Disease	MESH:D020196
2196841	1194	1202	embolism	Disease	MESH:D004617
2196841	1204	1215	haemorrhage	Disease	MESH:D006470
2196841	1219	1225	trauma	Disease	MESH:D014947
2196841	1244	1247	CAS	Disease	MESH:D064807
2196841	1357	1370	physostigmine	Chemical	MESH:D010830
2196841	Positive_Correlation	MESH:D006221	MESH:D064807
2196841	Positive_Correlation	MESH:D001285	MESH:D064807
2196841	Positive_Correlation	MESH:D012601	MESH:D064807
2196841	Positive_Correlation	MESH:D001569	MESH:D064807
2196841	Positive_Correlation	MESH:D011398	MESH:D064807
2196841	Negative_Correlation	MESH:D010830	MESH:D064807

